Global Cord Blood


ATLANTA, GA – – (Globe Newswire – April 23, 2024) – – A shareholder class action lawsuit has been filed against Global Cord Blood Corporation (“Global Cord” or the “Company”) (NYSE: CO). The lawsuit alleges that Defendants made materially false and misleading statements and/or failed to disclose material adverse information regarding the Company’s business, operations, and prospects, including allegations that Global Cord employed a capital allocation strategy designed to reserve funds for Company insiders and related parties rather than for the benefit of Company shareholders.

If you bought Global Cord shares between June 4, 2019 and May 3, 2022, and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Marshall Dees, Esq. at, by toll-free telephone at (888)-508-6832 or, you may visit the firm’s website at to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is June 24, 2024.

Registration Deadline

Lead Plaintiff Deadline Has Passed

June 24, 2024

Submit Your Information

Shares Purchased(Required)
Date of Shares Purchased
Number of Shares Acquired
Acquisition Price Per Share
Shares Sold
Date of Shares Sold
Number of Shares Sold
Selling Price Per Share